GMiA 2nd edition Code of Practice out for consultation 30 March 2010

GMiA

Latest news

8 May 2012: Patients benefit from PBS being untouched in Federal Budget
30 March 2012 : The generic medicines industry is driving significant savings to the public purse
20 March 2012: Members of GMiA strongly welcome the passing of the Intellectual Property Laws Amendment (Raising the Bar) Bill 2011
23 February 2012: Important news for all Community Pharmacists and Pharmacy Owners: GMiA call to action to pharmacists to maximise profitability in 2012
20 February 2012: Generic medicines key to unlocking hundreds of millions of dollars in savings for Australian economy: says MJA
8 February 2012: The generic medicines sector will drive hundreds of millions of savings to the PBS in 2012 - eliminating the need for further PBS cuts
27 January 2012: Today GMiA lodges its pre-budget submission 2012/13 with the Commonwealth Government delivering a win-win for patients and the economy
16 January 2012: Generic medicines key to ensuring Australia can afford increased use in prescription medicines
16 December 2011: New PBS prices announced today will drive significant savings to PBS
12 December 2011: A sustainable PBS must be the priority for new Health Minister says Generic Medicines sector
9 December 2011: GMiA Responds to the TGA′s Blueprint Report
30 November 2011: MYEFO figures show generic medicines continue to play critical role in managing the PBS growth rate
31 October 2011: GMiA completes its 2011 Code Review and sets about to implement recommendations
17 October 2011: GMiA Chairman comments on PBS cuts and the loss of pharmaceutical manufacturing facilities in Australia
30 September 2011: GMiA commits to discussions with government and other stakeholders on PBS policy
18 August 2011: GMiA welcomes Senate Finance and Administration References Committee report on Government administration of the PBS
20 July 2011: GMiA welcomes the release of “The Review to improve the transparency of the Therapeutic Goods Administration”
22 July 2011: Sponsors of PBS listed products must be given the opportunity to successfully obtain price increases to ensure continued access of medicines to patients
5 July 2011: GMiA welcomes Dr Suzanne Hill as new Chair of PBAC
30 June 2011: Government report on inappropriate use of intellectual property rights in medicines
27 June 2011: GMiA launches brand campaign into pharmacy
20 June 2011: Joint Australian / New Zealand Therapeutic Producst Agency
26 June 2011: Australia’s data exclusivity provisions are a sensible middle ground
12 May 2011: GMiA welcomes an important amendment to the Copyright Act to protect the right of the Australian public to access generic medicines
5 May 2011: GMiA welcomes an important amendment to the Intellectual Property Laws to support innovation by encouraging investment in research and technology in Australia
10 January 2011: GMiA Posts Educational Event Reports
8 December 2010: Spirit Pharmaceuticals joins GMiA
1 December 2010: GMiA Code of Practice receives ACCC authorisation
8 November 2010: Patients′ access to life saving, prescription medicines under threat
20 October 2010: The National Health Amendment (PBS) Bill 2010 should not be supported
11 May 2010: Damaging grab for cash will export jobs rather than pharmaceuticals
27 September 2010: Politicians must safeguard Australians′ access to necessary medicines
6 May 2010: Reported reforms to Pharmaceutical Benefits Scheme (PBS) will cost jobs, reduce investments and exports, and compromise access to medicines
1 March 2010: GMiA self-regulatory Code of Practice adopted
24 July 2009: Australian medicines makers will miss share of $150 billion export market
8 May 2009: Study finds generic medicines in Australia cheaper than in the US
30 March 2010: GMiA 2nd edition Code of Practice out for consultation

Latest news

30 March 2010

GMiA 2nd edition Code of Practice out for consultation

Today the Generic Medicines Industry Association (GMiA) applied to the Australian Competition and Consumer Commission (ACCC) for authorisation of the second edition of the GMiA Code of Practice.

The application by GMiA for authorisation by ACCC of its Code of Practice continues to formalise the high standards of behaviour adhered to by members.

The second edition of the Code of Practice strengthens the first edition by providing stakeholders clearer guidance and transparency of Code processes. In particular, enhancements have been made to the Code complaint processes.

Members of GMiA will continue to adhere to the current (first) edition of the GMiA Code of Practice during the six month ACCC authorisation review period.

GMiA welcomes and encourages feedback from stakeholders. Feedback can be submitted to code@gmia.com.au.

GMiA Code of Practice 1st Edition

Click here to view draft second edition GMiA Code of Practice

The Generic Medicines Industry Association (GMiA) is the national association representing companies that manufacture, supply and export generic medicines. The generic medicines sector is a high value-add sector delivering significant benefits to the Australian public by way of affordable medicines and high skilled jobs.

Contact: Kate Lynch 0432 500 308

© GMiA 2012